Evidence map›Paper›PMID 33424091›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2020

Age Distribution of Clinical Symptoms, Isolation, Co-morbidities and Case Fatality Rate of COVID-19 Cases in Najaf City, Iraq.

Rihab H Al-Mudhaffer, Salam W Ahjel, Saif M Hassan, Abdulkareem A Mahmood, Najah R Hadi

Abstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rihab H Al-MudhafferMiddle Euphrates Unit for Cancer Research, Faculty of Medicine, University of Kufa, Iraq.
Salam W AhjelDepartment of Pharmacy, of Al-Zahrawi University College, Karbala, Iraq.
Saif M HassanDepartment of Family and Community Medicine, Faculty of Medicine, University of Kufa.
Abdulkareem A MahmoodDepartment of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Iraq.
Najah R HadiDepartment of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe first case of coronavirus disease 2019 (COVID-19) in holy Najaf city in February 22, 2020. The outbreak then rose up all over Iraq from 519 cases and 20 deaths in June 2, 2020 to 3484 cases and 72 deaths per day in August 10, 2020 per 24 hours.

aimThe aim of the study is to describe the distribution of confirmed cases by age, demographic factors, isolation, comorbidities and case fatality rate.

methodsProspectively collected and analyzed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. The demographic and clinical outcomes data of 1153 diagnosed patients were collected from consecutive patients, analyzed, and described. About two third of cases 789 (68.4%) acquired infection through contact with positive patients.

resultsThe reported cases were 743 (64.4%) males and 410 (35.6%) females with large number among age range 21 to 50 years. The most frequent presenting symptoms were fever, sore throat and dyspnea or cough, most of patients; 868 (75%) patients were isolated at home versus 285 (24.72) patients required hospitalization which represented the intermediate and sever cases. The overall case fatality rate was 2.4%.

conclusionMost of COVID-19 cases in this locality were male from urban areas. The common onset symptoms were the fever, sore throat and dyspnea or cough. Majority of cases were isolated and treated at home. The estimated case fatality rate was within the global range (2.4%).

Indexed as

AdolescentAdultAgedAge DistributionChildComorbidityCOVID-19Cross-Sectional StudiesFemaleHospitalizationHumansIraqMaleMiddle AgedPatient IsolationSurvival RatecoronavirusCOVID-19outbreaksymptoms

Identifiers

PMID33424091
PMCPMC7780775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.